Literature DB >> 7226025

Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma.

M M Ribeiro, J A Sarmento, M A Sobrinho Simões, J Bastos.   

Abstract

One hundred seventy-two patients with gastric carcinoma were studied (111 men and 61 women). Mean age was 54.0 +/- 11.2 years, and the overall five-year survival rate was 37.5%. There were four carcinomas in situ and one double carcinoma; the remaining 167 were classified as intestinal (112), diffuse (48), and atypical (7), according to Lauren; and as expanding (96) and infiltrative (71), according to Ming. Both classifications had prognostic significance; that of Lauren's could not be ascribed to sex and age of patients, to location of tumors, or to extent of disease, but appeared to be associated with the histologic pattern of regional lymph nodes. The prognostic significance of Ming's classification did not seem to depend upon sex and age of patients, location of tumors, or lymphoid response, but appeared to be partially related with extent of disease. The concurrent use of both classification did not provide further prognostic information.

Entities:  

Mesh:

Year:  1981        PMID: 7226025     DOI: 10.1002/1097-0142(19810215)47:4<780::aid-cncr2820470424>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  40 in total

1.  CT Perfusion evaluation of gastric cancer: correlation with histologic type.

Authors:  Dong Ho Lee; Se Hyung Kim; Ijin Joo; Joon Koo Han
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  New observations regarding Helicobacter pylori and gastric cancer in Mongolia.

Authors:  Boldbaatar Gantuya; Dashdorj Bolor; Khasag Oyuntsetseg; Yansan Erdene-Ochir; Ruvjir Sanduijav; Duger Davaadorj; Tegshee Tserentogtokh; Dashdorj Azzaya; Tomohisa Uchida; Takeshi Matsuhisa; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2018-06-08       Impact factor: 5.753

3.  Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.

Authors:  Yan Cui; Shao-Bo Li; Xing-Chun Peng; Jun Wu; Guo-Hui Fu
Journal:  Dig Dis Sci       Date:  2015-07-15       Impact factor: 3.199

4.  Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients.

Authors:  J P Kim; Y W Kim; H K Yang; D Y Noh
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

5.  Association of macrophages detected with monoclonal antibody 25 F 9 with progression and pathobiological classification of gastric carcinoma.

Authors:  G Heidl; P Davaris; G Zwadlo; M S Jagoda; S Düchting; E Bierhoff; T Grüter; V Krieg; C Sorg
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

6.  Morphological predictors of survival in advanced gastric carcinoma univariate and multivariate analysis.

Authors:  P Schmitz-Moormann; C Pohl; G W Himmelmann; K Neumann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Discrepancies in the histologic type between biopsy and resected specimens: a cautionary note for mixed-type gastric carcinoma.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Toshiyuki Kosuga; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis.

Authors:  Liduan Zheng; Mixia Weng; Jun He; Xiuping Yang; Guosong Jiang; Qiangsong Tong
Journal:  Virchows Arch       Date:  2009-12-05       Impact factor: 4.064

Review 9.  Occupation and gastric cancer.

Authors:  A Raj; J F Mayberry; T Podas
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

10.  Prognostic value of Goseki histological classification in adenocarcinoma of the cardia.

Authors:  M G Fontana; M La Pinta; D Moneghini; V Villanacci; F Donato; G Rindi; S Paparini; C Baronchelli; G Bertoli; P Alquati
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.